Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
Open Access
- 29 February 2016
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 5 (6) , 1307-1318
Abstract
Lifestyle‐related risk factors such as hyperglycemia and dyslipidemia have been associated with several cancers. However, studies exploring their link with prostate cancer (PCa) clinicopathological characteristics are sparse and inconclusive. Here, we investigated the associations between serum metabolic markers and PCa clinicopathological characteristics. The study comprised 14,294 men from the Swedish Apolipoprotein MOrtality RISk (AMORIS) cohort who were diagnosed with PCa between 1996 and 2011. Univariate and multivariable logistic regression were used to investigate the relation between glucose, triglycerides and total cholesterol and PCa risk categories, PSA, Gleason score, and T‐stage. Mean age at time of PCa diagnosis was 69 years. Men with glucose levels >6.9 mmol/L tend to have PSAμg/L, while those with glucose levels of 5.6–6.9 mmol/L had a greater odds of PSA>20 μg/L compared to PSA 4.0–9.9 μg/L. Hypertriglyceridemia was also positively associated with PSA>20 μg/L. Hyperglycemic men had a greater odds of intermediate‐ and high‐grade PCa and advanced stage or metastatic PCa. Similarly, hypertriglyceridemia was positively associated with high‐grade PCa. There was also a trend toward an increased odds of intermediate risk localized PCa and advanced stage PCa among men with hypertriglyceridemia. Total cholesterol did not have any statistically significant association with any of the outcomes studied. Our findings suggest that high serum levels of glucose and triglycerides may influence PCa aggressiveness and severity. Further investigation on the role of markers of glucose and lipid metabolism in influencing PCa aggressiveness and severity is needed as this may help define important targets for intervention.Keywords
Funding Information
- Cancerfonden
- Forskningsrådet för hälsa, arbetsliv och välfärd
- National Institute for Health Research
- Guy's and St Thomas' NHS Foundation Trust
- King's College London
This publication has 73 references indexed in Scilit:
- Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancerProstate Cancer and Prostatic Diseases, 2013
- Screening for prostate cancerCochrane Database of Systematic Reviews, 2013
- The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist CastrationCell Stem Cell, 2012
- Metabolic alterations and targeted therapies in prostate cancerThe Journal of Pathology, 2010
- Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialCancer Epidemiology, Biomarkers & Prevention, 2009
- Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohortCancer Causes & Control, 2009
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and PancreasGastroenterology, 2007
- Risk factors for prostate cancer incidence and progression in the health professionals follow‐up studyInternational Journal of Cancer, 2007
- On the Origin of Cancer CellsScience, 1956